High doses of opioids usage for amyotrophic lateral sclerosis patients with non-invasive ventilation.
Acta Neurol Belg
; 124(1): 101-107, 2024 Feb.
Article
em En
| MEDLINE
| ID: mdl-37543533
ABSTRACT
INTRODUCTION:
While opioids have been found to be useful in relieving suffering in amyotrophic lateral sclerosis (ALS), there is a lack of evidence concerning how and how much to use them in practice. This study was conducted to clarify how opioids were used for patients with ALS.METHODS:
We performed a retrospective case-based analysis at a single tertiary neurology center in Tokyo from 2010 to 2018. We enrolled patients with ALS who had died before the end of 2018. We examined the opioid dosage equivalent of morphine hydrochloride and patients' clinical backgrounds, focusing on ventilatory support.RESULTS:
Morphine was administered in 110 patients with ALS, and 84 were followed up until their death. Of these 84 patients, 57 (69.9%) did not use mechanical ventilation until death (no-MV group), and 21 (22.9%) utilized only non-invasive ventilation (NIV group). Final morphine dosage in the NIV group was significantly higher (mean 65.7 mg [SD 54.6], range 10-200 mg) than in the no-MV group (mean 31.7 mg [SD 26.9], range 0-120 mg; p = 0.015, Welch's t-test). The NIV group needed psychotropic drugs more frequently than the no-MV group (62% [n = 13] vs. 35% [n = 20]).CONCLUSION:
Patients in the NIV group used opioids for a statistically significantly longer time and at a higher dose than those in the no-MV group. Symptom control with opioids alone may be difficult, and the development of multifaceted evaluation and care is desirable.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Ventilação não Invasiva
/
Esclerose Lateral Amiotrófica
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article